Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting
Active cancer targeting consists of the selective recognition of overexpressed biomarkers on cancer cell surfaces or within the tumor microenvironment, enabled by ligands conjugated to drug carriers. Nanoparticle (NP)-based systems are highly relevant for such an approach due to their large surface...
Saved in:
| Main Authors: | Alessandra Spada, Sandrine Gerber-Lemaire |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Nanomaterials |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-4991/15/3/158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy
by: Ali MS, et al.
Published: (2025-06-01) -
Advancements in Targeted Therapy for Oral Cancer: A Mini Review
by: Sakshi G. Ingole, et al.
Published: (2025-05-01) -
miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
by: Cristina Migliore, et al.
Published: (2018-07-01) -
Advanced photoluminescent nanomaterials for targeted bioimaging of cancer cells
by: Tooba Mohammadi, et al.
Published: (2025-01-01) -
17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells
by: Sun Young Yoon, et al.
Published: (2025-05-01)